Analystreport

Stoke Therapeutics (NASDAQ:STOK) was given a new $28.00 price target on by analysts at Canaccord Genuity Group Inc..

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report